Gastric cancer immunotherapy is advancing rapidly, bringing hope for better patient outcomes. Therefore, OncologyTube is excited to share insights from…
Browsing: Gastrointestinal Cancer Treatment
Gastrointestinal Cancer Treatment Resources
Gastrointestinal cancer treatment is advancing rapidly, and OncologyTube’s Gastrointestinal Cancer Treatment category is your trusted source for the latest insights. Discover expert-led videos, clinical trial updates, and research from leading oncologists. Whether you’re exploring treatments for colorectal, pancreatic, or gastric cancers, our curated content supports patients and professionals. Learn about breakthroughs like the KEYNOTE-811 trial for gastric cancer and immunotherapy for microsatellite instability-high (MSI-H) tumors.
Why Trust OncologyTube?
We feature renowned experts like Dr. Zev Wainberg, a gastrointestinal oncology specialist, delivering credible and actionable insights. Our partnerships with top institutions ensure reliable, up-to-date information.
Latest Gastrointestinal Cancer Research
Stay informed with cutting-edge studies, such as ASCO 2025 updates on anti-HER2 therapies and KRAS G12C inhibitors. Our videos simplify complex topics like biomarker testing and neoadjuvant chemotherapy for patients and caregivers.
Patient and Professional Resources
OncologyTube provides tools for both patients and providers. Patients can access support resources, while professionals find updates on guidelines from ASCO and ESMO. Watch interviews addressing treatment challenges, such as managing pancreatic cancer recurrence.
Explore More
Dive into related content like Dr. Wainberg’s video on colorectal cancer immunotherapy or visit our Immunotherapy Category. For guidelines, explore the National Cancer Institute or ASCO.
Introduction to CT Scans and Cancer Computed Tomography (CT) scans are vital for diagnosing cancer, injuries, and chronic diseases. However,…
The Matterhorn Trial, a landmark phase III study published in the New England Journal of Medicine, evaluates durvalumab, an anti-PD-L1…
Digestive cancers therapeutics takes center stage as these cancers—esophageal, gastric, biliary, pancreatic, hepatocellular, and colorectal—account for 33-35% of global cancer…
The Top 10 GI Trials at ASCO 2025 are here (with Dates and Times), and OncologyTube proudly presents an exclusive…
Date: March 19, 2025 On March 19, 2025, the U.S. Food and Drug Administration (FDA) granted traditional approval to pembrolizumab…
March 4, 2025 New Treatment Option for ESCC Patients The U.S. Food and Drug Administration (FDA) has approved TEVIMBRA® (tislelizumab-jsgr)…
Introduction: Recent data from the American Society of Clinical Oncology (ASCO) GI Cancers Symposium 2025, as detailed in their educational…
Overview: The results from the Phase 3 CheckMate-8HW trial have just been released, demonstrating significant improvements in outcomes for patients…
Abstract: Circulating tumor DNA (ctDNA) has a short half-life (<2 hours) which may permit real-time monitoring of tumor status. This…
In the rapidly evolving field of cancer treatment, the application of comprehensive genomic profiling (CGP) via liquid biopsy has become…
In a recent interview with Dr. Ignacio Garrido-Laguna from the University of Utah Health, we gained fascinating insights into the…
In an enlightening discussion at the latest medical symposium, Dr. Jonathan Nowak, MD from Brigham and Women’s Hospital, shared critical…
The latest findings from the BREAKWATER study, a phase 3 clinical trial, have shown significant strides in improving treatment outcomes…
By: Elizabeth Catherine Smyth – Cambridge University Hospitals NHS Foundation Trust Background: Oesophagogastric adenocarcinoma (OGA) remains a significant global health…
Background: The treatment landscape for well-differentiated gastroenteropancreatic neuroendocrine tumors (GEP-NETs) has been slow to evolve, with limited evidence supporting the…
We asked 5 top KOLS at ASCO GI 2024 the same questions on MRD and CTDNA testing. You might be…
Warning: Undefined array key "file" in /home2/medicusn/public_html/.website_03b234a0/wp-content/themes/smart-mag/inc/media.php on line 688
… Anup Kasi, MD, Associate Professor and Vice Chair of GI Oncology at the University of Kansas Medical Center, is…
Suneel Kamath, MD: [00:00:00] So this this trial that the tech 24 trial was really looking at a pan G.…
Van K. Morris, MD: [00:00:00] Thanks Allen for for having me and letting me represent our team of investigators who…
Naureen Starling, MD: [00:00:00] Of course. So AZUR-2, as you said, is a global study. Open label, randomized, running in…
Sakti Chakrabarti, MD: [00:00:00] So Dream GI is a national database through which we collect data on localized GI cancer…
Michael Weickert, PhD: [00:00:00] So the first thing I want to explain is Zelenirstat is a first in class therapy…
Thejus Jayakrishnan, MD: [00:00:00] Those of you who have listened to the keynote address today by Dr. Ng from Dana…
Sawyer Bawek, MD: So in colorectal cancer with liver metastasis, studies have shown that immunotherapy has a poor response on…
Anup Kasi, MD: [00:00:00] So this is an investigative initiated trial called the EPIC trial. Where we’re investigating n fotamibidotin,…
Simron Singh, MD: [00:00:00] So radioligand therapy is like in a new emerging treatment for cancer. where we try to…
Howard S. Hochster, MD: [00:00:00] Um, first of all, this is for late line colorectal cancer after the standard chemotherapy…
OncologyTube: [00:00:00] Okay. We’re here at ASCO GI 2024. And, we have the honor of, having Dr. Christopher Lieu, MD…
OncologyTube: [00:00:00] Okay, here we are at ASCO GI 2024. We have Dominik Paul Modest, MD medical doctor from Charite,University…
OncologyTube: [00:00:00] Okay. Okay, we’re here at ASCO GI 2024 and we have Dr. Anthony B. El-Khoueiry, MD a medical…
OncologyTube: [00:00:00] Okay, we’re here at ASCO GI 2024 and we have Dr. Dr. Riccardo Lencioni, MD medical doctor, professor…
OncologyTube: [00:00:00] We have Dr. Milind Javle, MD. He is from the Department of Gastrointestinal Medical Oncology at the University…
OncologyTube: [00:00:00] Okay, we’re here at ASCO GI 2024 and we have Jeanne Tie, MD a medical doctor, the medical…
OncologyTube: [00:00:00] Okay, we’re here at ASCO GI 2024 and we have Dr. Ghassan K. Abou-Alfa, MD, medical doctor from…
OncologyTube: [00:00:00] Okay, we’re here at ASCO GI 2024 and we have Dr. Ethan Ludmir, medical doctor and the assistant…
OncologyTube: Okay, we’re here at ASCO GI 2024. We have Dr. Manish Shah, medical doctor, and the director of gastrointestinal…
  OncologyTube: Okay, we’re here at ASCO GI 2024. We have Dr Stacy Cohen, medical doctor and an associate professor…
Transcript:   Okay, we’re here at ASCO G. I. 2024 and we have Dr. Vivek Sivaya, Medical Doctor, Chief Early…
Esophageal adenocarcinoma is a subtype of cancer that arises from the glandular cells in the esophagus, the muscular tube responsible…
In this video, Dr. Samuel Klempner, MD summarizes the phase 3 STAR-221 clinical trial investigating a novel treatment for advanced…
Sarbajit Mukherjee, MD, MS, Assistant Professor, Roswell Park Comprehensive Cancer Center conducted a study to investigate the efficacy of a…
Trimodality: In addition to Trastuzumab for HER2+ Esophageal Adenocarcinoma: NRG Oncology RTOG 1010 Phase III Trial Lisa Kachnic MD By…
Gastrointestinal Malignancies Research Advancements: Insights from Farshid Dayyani, MD By Farshid Dayyani, MD, PhD Thank you so much for inviting…
Question and Answer Session Joseph Chao, MD – ASCO 2022 Esophageal In-Depth Slides: MOASC Spotlight https://oncologytube.com/v/41288 Joseph Chao, MD -…
ASCO 2022 Esophageal In-Depth Slides: MOASC Spotlight  ASCO 2022 Esophageal Cancer Abstracts Highlights Abstracts of interest that were recently…
 Article: Transcript: Question – Please Tell Us About The EA 2142 Trial  So, at ASCO 2022 this year…
 Well this is a study to answer a very basic question that people have who are taking care of…
 Article: Transcript: Question – Please Tell Us About The 27-gene IO Score Thanks, Stephanie, I appreciate the invitation to…
Audio: So, at ASCO 2022 this year I had the opportunity to present the results of the EA 2142 clinical…
Platinum Chemotherapy: vs. Temozolomide/Capecitabine for Advanced GEPNENs: ECOG-ACRIN EA2142 Results Jennifer Eads MD By Jennifer Eads, MD So, at ASCO…
Well this is a study to answer a very basic question that people have who are taking care of individuals…
Well this is a study to answer a very basic question that people have who are taking care of individuals…
Audio: Thanks, Stephanie, I appreciate the invitation to interview with you today so I’m going to talk about how the…
DetermaIO algorithm and qPCR assay are used to show an association with molecular features of gastric cancer that have also…
Sepideh Gholami, MD, MAS, FACS, Liver and Pancreas Surgeon at UC Davis Medical Center, Cancer Researcher at UC Davis Health.…
Sepideh Gholami, MD, MAS, FACS, Liver and Pancreas Surgeon at UC Davis Medical Center, Cancer Researcher at UC Davis Health.…
Karyn A Goodman, MD, MS, Professor of Radiation Oncology, Professor of Medicine, Hematology and Medical Oncology at Icahn School of…
Karyn A Goodman, MD, MS, Professor of Radiation Oncology, Professor of Medicine, Hematology and Medical Oncology at Icahn School of…
Kristen Renee Spencer, DO, MPH, is a medical oncologist in the Liver Cancer and Bile Duct Cancer Program and Phase…
Kristen Renee Spencer, DO, MPH, is a medical oncologist in the Liver Cancer and Bile Duct Cancer Program and Phase…
Dr. Zev Wainberg is the Co-Director UCLA Gastro-Intestinal Oncology Program; Medical Director, UCLA Colorectal Cancer Center; Professor of Medicine, Division…
Dr. Zev Wainberg is the Co-Director UCLA Gastro-Intestinal Oncology Program; Medical Director, UCLA Colorectal Cancer Center; Professor of Medicine, Division…
Dr. Zev Wainberg is the Co-Director UCLA Gastro-Intestinal Oncology Program; Medical Director, UCLA Colorectal Cancer Center; Professor of Medicine, Division…
Dr. Zev Wainberg is the Co-Director UCLA Gastro-Intestinal Oncology Program; Medical Director, UCLA Colorectal Cancer Center; Professor of Medicine, Division…
Alessandra Prete, MD, Oncologist at Istituto Oncologico Veneto in Padua. In this video, she speaks about the ASCO GI 2022…
Alessandra Prete, MD, Oncologist at Istituto Oncologico Veneto in Padua. In this video, she speaks about the ASCO GI 2022…
Prof. Dr. med. Enrico de Toni, Medical Clinic and Polyclinic II at LMU Klinikum der Universität München. In this video,…
Prof. Dr. med. Enrico de Toni, Medical Clinic and Polyclinic II at LMU Klinikum der Universität München. In this video,…
Pashtoon Kasi, MD, MS, Director, Colon Cancer Research, Director, Liquid Biopsy Research, Sandra and Edward Meyer Cancer Center at Weill…
Pashtoon Kasi, MD, MS, Director, Colon Cancer Research, Director, Liquid Biopsy Research, Sandra and Edward Meyer Cancer Center at Weill…
Ryan Sugarman, MD, Strategic Partnerships Medical Director, Divison of Solid Tumor Oncology, and Assistant Attending of the Gastrointestinal Medical Oncology…
CheckMate 649: Long-Term Data Support Nivolumab Plus Chemotherapy but Not Nivolumab Plus Ipilimumab in Gastric Cancer This is a study…
Peter Kim, MD, Associate Professor, Department of Cardiology, Division of Internal Medicine at MD Anderson Cancer Center. In this video,…
Heinz-Josef Lenz, MD, is a professor in the Departments of Medicine and Preventive Medicine in Keck School of Medicine’s oncology…
Heinz-Josef Lenz, MD, is a professor in the Departments of Medicine and Preventive Medicine in Keck School of Medicine’s oncology…
Pashtoon Kasi, MD, MS, Director, Colon Cancer Research, Director, Liquid Biopsy Research, Sandra and Edward Meyer Cancer Center at Weill…
Pashtoon Kasi, MD, MS, Director, Colon Cancer Research, Director, Liquid Biopsy Research, Sandra and Edward Meyer Cancer Center at Weill…
Rutika Mehta, MD, MPH from Moffits Cancer Center. In this interview, Dr. Mehta speaks about the ASCO GI 2022 Abstract…
Rutika Mehta, MD, MPH, Medical Oncologist in Gastrointestinal Oncology at Moffitt Cancer Center. In this video, she speaks about the…
Shimoli Barot, MD, Hematology/Oncology Fellow at the Cleveland Clinic. In this video, she speaks about the ASCO GI 2022 Abstract…
Shimoli Barot, MD, Hematology/Oncology Fellow at the Cleveland Clinic. In this video, she speaks about the ASCO GI 2022 Abstract…
Thomas George, MD, FACP, Professor, MD-Hematology/Oncology from UF Health Cancer Center. In this video, he speaks about the ASCO GI…
Thomas George, MD, FACP, Professor, MD-Hematology/Oncology from UF Health Cancer Center. In this video, he speaks about the ASCO GI…
Michael C. Heinrich, FACP, MD, Professor of Medicine, School of Medicine, Cell and Developmental Biology Graduate Program, School of Medicine,…
Michael C. Heinrich, FACP, MD, Professor of Medicine, School of Medicine, Cell and Developmental Biology Graduate Program, School of Medicine,…
Samuel J Klempner, MD a gastrointestinal medical oncologist with a clinical and research focus in upper GI cancers, specifically gastroesophageal…
Katherine Pogue-Geile, Ph.D., Assistant Director of Molecular Profiling at NSABP Foundation. In this video, she speaks about the ASCO GI…
Samuel J Klempner, MD a gastrointestinal medical oncologist with a clinical and research focus in upper GI cancers, specifically gastroesophageal…
Katherine Pogue-Geile, Ph.D., Assistant Director of Molecular Profiling at NSABP Foundation. In this video, she speaks about the ASCO GI…
Ghassan Khaled Abou-Alfa, MD, MBA, Medical Oncologist, Attending Physician at Memorial Sloan Kettering Cancer Center. In this video, he speaks…
Ghassan Khaled Abou-Alfa, MD, MBA, Medical Oncologist, Attending Physician at Memorial Sloan Kettering Cancer Center. In this video, he speaks…
Jeremy Sharib, MD, Complex General Surgical Oncology Fellow at Duke University. In this interview, he speaks about ASCO GI 2022…
Jeremy Sharib, MD, Complex General Surgical Oncology Fellow at Duke University. In this interview, he speaks about ASCO GI 2022…
Rachna T. Shroff, MD, Associate Dean, Clinical and Translational Research, Associate Professor, Medicine – (Clinical Scholar Track), Chief, Section of…
Rachna T. Shroff, MD, Associate Dean, Clinical and Translational Research, Associate Professor, Medicine – (Clinical Scholar Track), Chief, Section of…
Al Benson III, MD, Professor, Medicine, Hematology-Oncology Division; Feinberg School of Medicine at Northwestern University. In this video he speaks…
Al Benson III, MD, Professor, Medicine, Hematology-Oncology Division; Feinberg School of Medicine at Northwestern University. In this video he speaks…
Afsaneh Barzi, MD, Ph.D., Director, Employer Strategy (AccessHope); Associate Professor, Department of Medical Oncology & Therapeutics Research at the City…
Afsaneh Barzi, MD, Ph.D., Director, Employer Strategy (AccessHope); Associate Professor, Department of Medical Oncology & Therapeutics Research at the City…
Erqi Pollom, MD, Assistant Professor of Radiation Oncology and, by courtesy, of Neurosurgery at Stanford Hospital and ClinicsLucile Packard Children’s…
Erqi Pollom, MD, Assistant Professor of Radiation Oncology and, by courtesy, of Neurosurgery at Stanford Hospital and Clinics, Lucile Packard…
Dr. Anwaar Saeed, MD, Associate Professor of Medicine, Division of Medical Oncology, Associate Director- Early Phase Program at University of…
Dr. Anwaar Saeed, MD, Associate Professor of Medicine, Division of Medical Oncology, Associate Director- Early Phase Program at University of…
Dr. Anwaar Saeed, MD, Associate Professor of Medicine, Division of Medical Oncology, Associate Director- Early Phase Program at University of…
Dr. Anwaar Saeed, MD, Associate Professor of Medicine, Division of Medical Oncology, Associate Director- Early Phase Program at University of…
Professor Eric Van Cutsem, MD, Ph.D., is full professor and Division Head of Digestive Oncology at the University of Leuven…
The DESTINY-Gastric02 study is a very important study because it’s the first study in western patients with HER2 positive Gastric…
Yelena Y. Janjigian, MD, Cheif, Gastrointestinal Oncology Service at Memorial Sloan Kettering Cancer Center. In this interview Dr. Janjigian speaks…
Yelena Y. Janjigian, MD, Cheif, Gastrointestinal Oncology Service at Memorial Sloan Kettering Cancer Center. In this interview Dr. Janjigian speaks…
Dr. Kohei Shitara is a Chief of Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa in Japan. In…
Dr. Kohei Shitara is a Chief of Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa in Japan. In…
Richard Francis Dunne, MD, Assistant Professor – Department of Medicine, Hematology/Oncology (SMD) at the University of Rochester Medical Center. In…
Richard Francis Dunne, MD, Assistant Professor – Department of Medicine, Hematology/Oncology (SMD) at the University of Rochester Medical Center. In…
Jelena Lukovic, MD, FRCPC, MPH, Radiation Onologist, University of Toronto, Princess Margaret Cancer Centre speaks about the ASTRO 2021 Abstract…
Jelena Lukovic, MD, FRCPC, MPH, Radiation Onologist, University of Toronto, Princess Margaret Cancer Centre speaks about the ASTRO 2021 Abstract…
Joseph Chao, MD from the City of Hope speaks about the Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite…
Jason Sicklick, MD, Surgical Oncologist, Associate Professor of Surgery at UC San Diego Health speaks about Establishment of Patient-derived Succinate…
Jason Sicklick, MD, Surgical Oncologist, Associate Professor of Surgery at UC San Diego Health speaks about Establishment of Patient-derived Succinate…
Jason Sicklick, MD, Surgical Oncologist, Associate Professor of Surgery at UC San Diego Health speaks about Location of Gastrointestinal Stromal…
Jason Sicklick, MD, Surgical Oncologist, Associate Professor of Surgery at UC San Diego Health speaks about Location of Gastrointestinal Stromal…
Ajay Goel, Ph.D., AGAF, chair of City of Hope’s Department of Molecular Diagnostics and Experimental Therapeutics speaks about Assessment of…
Ajay Goel, Ph.D., AGAF, chair of City of Hope’s Department of Molecular Diagnostics and Experimental Therapeutics speaks about Assessment of…
Joseph Chao, MD from the City of Hope speaks about the Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite…
David Illson, MD, Ph.D., Memorial Sloan Kettering Cancer Center and a professor of medicine at Weill Cornell Medical College speaks…
Ajay Goel, Ph.D., AGAF, chair of the Department of Molecular Diagnostics and Experimental Therapeutics at City of Hope speaks about…
Yelena Y. Janjigian, MD from Memorial Sloan Kettering Cancer Center speaks about ASCO 2021 Abstract FDA Approves Merck’s KEYTRUDA® (pembrolizumab)…
David Ilson, MD from the Memorial Sloan Kettering Cancer Center speaks about the Top 5 ASCO 2021 Abstracts in Gastrointestinal…
Timothy Ritter, MD, Senior Medical Director, Department of Research and Education GI Alliance Research speaks about U.S. FDA Grants De…
Linghua Wang, MD, PhD of MD Anderson speaks about Single-cell Analysis Of Metastatic Gastric Cancer Finds Diverse Tumor Cell Populations…
Manish A. Shah, MD from Weill Cornell Medicine and New York-Presbyterian discuss the ASCO Pubs – Phase III Study to…
Sheela Rao, MDS Consultant Medical Oncologist, The Royal Marsden NHS Foundation Trust discusses Incyte Announces Acceptance and Priority Review of…
Josep Tabernero, MD, PhD, Head of Medical Oncology at Vall d’Hebron Barcelona Hospital, and Director, Vall d’Hebron Institute of Oncology…
Sophie G Kellaway and Prof Constanze Bonifer from the Institute of Cancer and Genomic Sciences, University of Birmingham speaks about…
Kohei Shitara, MD, Chief, Department of Gastrointestinal Oncology of the National Cancer Center Hospital East, Kashiwa discusses The impact of…
Michele Ghidini, MD, Ph.D., Medical Oncologist, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico Milan, Italy speaks about Body weight loss…
Prof. Dan Aderka of the Sheba Medical Center discusses the Optimal Sequence of Targeted Agents for All RAS & BRAF…
Shahid Gilani, MD from University Hospital Of North Midlands speaks about the Impact of haemoglobin level and blood transfusion on…
Visit https://BeaconMedIC.com for more media and information.Subscribe to audio podcast at http://BTJBeacon.libsyn.com/rss/audioDrs. Charu Aggarwal and Jack West host Dr. Mark…
Shailja Shah, MD, MPH. at Vanderbilt Ingram Cancer Center discusses a Study which gauges specific site gastric cancer risks among…
Ari Rosenberg, MD at The University of Chicago discusses an abstract from ASCO 2020 entitled Dose and volume de-escalation for…
Benoit You, MD, Ph.D. from Centre Hospitalier Lyon-Sud discusses an ASCO 2020 abstract entitled ROPHIMMUN phase II trial, cohort A…
Johanna C. Bendell, MD from Sarah Cannon discusses and ASCO 2020 abstract entitled A phase I/II, two-part, multicenter, first-in-human study…
Ajay Goel, Ph.D. of the City of Hope speaks about the AACR 2020 Abstract 1084: EpiPanGI-Dx: A cell-free DNA methylation…
Charles S. Fuchs, MD, MPH at Yale Cancer discusses how Checkpoint Inhibitors are a “real player” in Gastric Cancers. Bottom…
Charles S. Fuchs, MD, MPH at Yale Cancer discusses the Current Role for Pembrolizumab in Gastric Cancer using the latest…
Charles S. Fuchs, MD, MPH at Yale Cancer gives an overview of a study presented at ASCO 2020 entitled Pembrolizumab…
In this edition of The Onco’Zine Brief, Peter Hofland, Ph.D., talks with Vince McRuiz and Margo Shoup, MD, FACS.Margo Shoup…
Margaret von Mehren, MD of Fox Chase Cancer Center @FoxChaseCancer discusses the FDA Full Approval of Deciphera Pharmaceuticals’ QINLOCK for…
Margaret von Mehren, MD of Fox Chase Cancer Center @FoxChaseCancer discusses the FDA Full Approval of Deciphera Pharmaceuticals’ QINLOCK for…
Margaret von Mehren, MD of Fox Chase Cancer Center @FoxChaseCancer discusses the FDA Full Approval of Deciphera Pharmaceuticals’ QINLOCK for…
Zev A. Wainberg, MD Associate Professor Of Medicine Co-Director GI Oncology Program David Geffen School of Medicine at UCLA gives…
Experience with COVID-19 in Wuhan, China shows up to half of patients present with a digestive symptom as chief complaint…
– Data from pivotal study demonstrate safety and efficacy regardless of prior gastrectomy in previously treated patients with metastatic gastric…
Earn CME: https://naccme.com/program/19-gdugi-2 In this webcast from the ‘Making Progress in Advanced Hepatocellular Carcinoma with Targeted Agents: Considerations for Therapeutic…
Bradley E. Bernstein, MD @BradEBernstein @willflavahan of @MassGeneralNews answers how this affects clinicians on the cause of drug resistance found…
Most cases of gastrointestinal stromal tumor (GIST), a form of soft tissue cancer (sarcoma), are caused by gene mutations that…
Bradley E. Bernstein, MD @BradEBernstein @willflavahan of @MassGeneralNews answers commonly asked questions on the cause of drug resistance found in a form…
Bradley E. Bernstein, MD @BradEBernstein @willflavahan of @MassGeneralNews explains the cause of drug resistance found in a form of intestinal tumor. ___________…
Thomas A. Abrams Senior Physician and Assistant Professor of Medicine at Harvard Medical School tells us his thoughts on KEYNOTE-62.…
Lowell Anthony MD Of Markey Cancer Center Discusses When Do You Prescribe Bland Vs Chemo Or Radio Embolization: Chemo Embolization…
Lowell Anthony MD Of Markey Cancer Center Discusses Inducing Embolization Syndrome When Performing infarction: Not Uncommon To Take 4-8 Weeks…
Lowell Anthony MD Of Markey Cancer Center Discusses Evaluating mTOR Inhibitor Everolimus With Embolotherapy: Objective Response Rate Of 57 We…
Yousuf Zafar, MD, discusses the importance of patient care. Financial barriers to clinical trial enrollment are an area of active…
Yousuf Zafar, MD, discusses the importance of questioning the qaulity and completenesss of Data. Financial barriers to clinical trial enrollment…
Yousuf Zafar, MD, discuses the role of Real World Evidence in cancer care. Financial barriers to clinical trial enrollment are…
Dr. Joseph Tabernero, MD, discusses the safety profile for Pembrolizumab. Background: KEYNOTE062 (NCT02494583) was a randomized, active controlled study of…
Dr. Joseph Tabernero, MD, discusses the phase 3 keynote-062 study. Background: KEYNOTE062 (NCT02494583) was a randomized, active controlled study of…
Nicholas Rohs MD @NickRohsMD Of Mount Sinai Discusses Combining Chemo & Immunotherapy Did Not Help Patients: Hope To See Survival…
Nicholas Rohs MD @NickRohsMD Of Mount Sinai Discusses Updates In Esophageal & Gastric Cancers: When Dose Of Xeloda & Oxaliplatin…
Nicholas Rohs MD @NickRohsMD Of Mount Sinai Discusses Lower Doses Of Xeloda & Oxaliplatin: Physicians Would Be Happy To Give…
Nicholas Rohs MD @NickRohsMD Of Mount Sinai Discusses Frontline KEYTRUDA In Gastroesophageal Cancer: Patients In Immunotherapy Arm Had Significantly Lower…
Alok Khorana, MD Of The Cleveland Clinic Discusses CASSINI Study Results: Reduction In Blood Clots When Taking Daily Rivaroxaban, No…
Josep Llovet, MD Of Mount Sinai School of Medicine Discusses Ramucirumab For Sorafenib Intolerant Patients With HCC: 8 Month Median…
Josep Llovet, MD Of Mount Sinai School of Medicine Discusses Ramucirumab Study: Good Safety Profile & Patients With Aggressive Tumors…
Josep Llovet, MD Of Mount Sinai School of Medicine Discusses When To Use Ramucirumab: Second Line & Aggressive Tumors, Moving…
John Strickler, M.D. Assistant Professor Of Medicine At Duke Cancer Institute, Discusses KEYNOTE-181 Esophageal Cancer Study. At The 2019 Gastrointestinal…
Ghassan Abou-Alfa, M.D. Attending Physician At Memorial Sloan Kettering Cancer Center, Discusses Embolization Therapy For Liver Cancer. At The 2019…
Ghassan Abou-Alfa, M.D. Attending Physician At Memorial Sloan Kettering Cancer Center, Discusses Data On Combining TKIs & Checkpoint Inhibitors In…
Ghassan Abou-Alfa, M.D. Attending Physician At Memorial Sloan Kettering Cancer Center, Discusses Checkpoint Inhibitors In The Treatment Of Liver Cancer.…
Ghassan Abou-Alfa, M.D. Attending Physician At Memorial Sloan Kettering Cancer Center Discusses, New Therapies In The Treatment Of Liver Cancer.…
Bassel El-Rayes, M.D. Professor & Vice Chair For Clinical Research, Department Of Hematology & Medical Oncology Emory University School Of…
Bassel El-Rayes, M.D. Professor & Vice Chair For Clinical Research, Department Of Hematology & Medical Oncology Emory University School Of…
Martine Extermann, M.D. Program Leader In The Senior Adult Oncology Program, Moffit Cancer Center, Discusses The Importance Of Precision Medicine…
Martine Extermann, M.D. Program Leader In The Senior Adult Oncology Program, Moffit Cancer Center, Discusses Elderly Patients Benefit From Third…
Martine Extermann, M.D. Program Leader In The Senior Adult Oncology Program, Moffit Cancer Center, Discusses Thoughts On Third Line Study…
Raymond Wadlow, M.D. Medical Oncologist At Inova Fairfax Hospital Discusses Correlation Between Modified Resist Criteria In HCC & Overall Survival…
Raymond Wadlow, M.D. Medical Oncologist At Inova Fairfax Hospital Discusses REFLECT Phase 3 Study Utilizing Lenvatinib & Recent Approval Of…
Raymond Wadlow, M.D. Medical Oncologist At Inova Fairfax Hospital Discusses Data On KETNOTE-181 Esophageal Cancer Study Utilizing Pembrolizumab. At The…
Zev Wainberg, M.D. Co-Director UCLA Gastro-Intestinal Oncology Program, Medical Director, UCLA Colorectal Hematology Oncology David Geffen School Of Medicine At…
Zev Wainberg, M.D. Co-Director UCLA Gastro-Intestinal Oncology Program, Medical Director, UCLA Colorectal Hematology Oncology David Geffen School Of Medicine At…
Richard Finn, MD Professor of Clinical Medicine, Department of Medicine, Division of Hematology/ Oncology, Geffen School of Medicine, UCLA discusses…
Richard Finn, MD Professor of Clinical Medicine, Department of Medicine, Division of Hematology/ Oncology, Geffen School of Medicine, UCLA discusses…
Richard Finn, MD Professor of Clinical Medicine, Department of Medicine, Division of Hematology/ Oncology, Geffen School of Medicine, UCLA discusses…
David Ilson, MD, PhD Attending Physician, Memorial Sloan Kettering Cancer Center, Professor of Medicine, Weill Cornell Medical College, Discusses The…
David Ilson, MD, PhD Attending Physician, Memorial Sloan Kettering Cancer Center, Professor of Medicine, Weill Cornell Medical College, Discusses The…
David Ilson, MD, PhD Attending Physician, Memorial Sloan Kettering Cancer Center, Professor of Medicine, Weill Cornell Medical College, Discusses Pembrolizumab,…
Nevena Damjanov, MD, Chief of GI Oncology, Abramson Cancer Center at Penn Presbyterian, University of Pennsylvania discusses, The Impact Of…
Nevena Damjanov, MD, Chief of GI Oncology, Abramson Cancer Center at Penn Presbyterian, University of Pennsylvania discusses, Sequencing TKIs In…
Nevena Damjanov, MD, Chief of GI Oncology, Abramson Cancer Center at Penn Presbyterian, University of Pennsylvania discusses, Thoughts On The…
Nevena Damjanov, MD, Chief of GI Oncology, Abramson Cancer Center at Penn Presbyterian, University of Pennsylvania discusses, Stereotactic Body Radiation…
Alan Venook, MD, Shorenstein Associate Director for Program Development, Helen Diller Family Comprehensive Cancer Center, Professor, Department of Medicine, UCSF,…
Alan Venook, MD, Shorenstein Associate Director for Program Development, Helen Diller Family Comprehensive Cancer Center, Professor, Department of Medicine, UCSF,…
David Ilson, MD, PhD Attending Physician, Memorial Sloan Kettering Cancer Center, Professor of Medicine, Weill Cornell Medical College, Discusses Pembrolizumab…
David Ilson, MD, PhD Attending Physician, Memorial Sloan Kettering Cancer Center, Professor of Medicine, Weill Cornell Medical College, Discusses Results…
Rachna Shroff, MD Chief, Section of GI Medical Oncology, Associate Professor of Medicine, Division of Hematology/Oncology, University of Arizona Cancer…
Rachna Shroff, MD Chief, Section of GI Medical Oncology, Associate Professor of Medicine, Division of Hematology/Oncology, University of Arizona Cancer…
Rachna Shroff, MD Chief, Section of GI Medical Oncology, Associate Professor of Medicine, Division of Hematology/Oncology, University of Arizona Cancer…
Andrew X. Zhu, MD, PhD Associate Professor, Department of Medicine, Harvard Medical School, Director, Liver Cancer Research, Medicine, Massachusetts General…
Andrew X. Zhu, MD, PhD Associate Professor, Department of Medicine, Harvard Medical School, Director, Liver Cancer Research, Medicine, Massachusetts General…
Andrew X. Zhu, MD, PhD Associate Professor, Department of Medicine, Harvard Medical School, Director, Liver Cancer Research, Medicine, Massachusetts General…
Richard Kim, MD, Gastrointestinal Oncology Department, Moffitt Cancer Center, Assistant Professor of Oncology, University of South Florida College of Medicine,…
Richard Kim, MD, Gastrointestinal Oncology Department, Moffitt Cancer Center, Assistant Professor of Oncology, University of South Florida College of Medicine,…
Richard Finn, MD Professor of Clinical Medicine, Department of Medicine, Division of Hematology/ Oncology, Geffen School of Medicine, UCLA discusses…
Do-Youn Oh, M.D., of Seoul National University Hospital discusses Treating Advanced Biliary Cancer: M7824 Data. At ESMO Oncology Conference -…
Do-Youn Oh, M.D., of Seoul National University Hospital discusses Pembrolizumab Monotherapy In Biliary Cancer. At ESMO Oncology Conference – Munich,…
Do-Youn Oh, M.D., of Seoul National University Hospital discusses Future Of Biliary Cancer Treatment. At ESMO Oncology Conference – Munich,…
Do-Youn Oh, M.D., of Seoul National University Hospital discusses Future Of Biliary Cancer Treatment. At ESMO Oncology Conference – Munich,…
Michael Davidson, M.D., Royal Marsden Hospital, discusses Gastric & Esophageal Cancer: Treating Female Patients. At ESMO Oncology Conference – Munich,…
Michael Davidson, M.D., Royal Marsden Hospital, discusses Gender Differences: Gastric & Esophageal Cancer Treatment. At ESMO Oncology Conference – Munich,…
Recent approvals in hepatocellular carcinoma (HCC) have increased the treatment options available for patients with this disease, leading to improved…
Dr. John Kisiel, MD, Mayo Clinic, talks Setting Specificity and Sensitivity for Tests | Involves recruiting up to 500 At-Risk…
Dr. John Kisiel, MD, Mayo Clinic, talks Sensitivity for BCLC for Stage A was 93%| Detect Hepatocellular Carcinoma Lesions in…
Dr. John Kisiel, MD, Mayo Clinic, talks about Fairly Consistent Distribution of Liver Diseases | No Association with Specific Diseases…
Dr. John Kisiel, MD, Mayo Clinic, talks about Develop Novel, Non-Invasive Biomarkers | Clinical Validation Study in Hepatocellular Carcinoma for…